Early Covid Treatments Could Be ‘Bridge’ to Vaccine, Fauci Says

Ref: Bloomberg
  • Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, suggested that monoclonal antibodies that stop SARS-CoV-2 from spreading in the body are among promising strategies for averting severe illness from COVID-19 before vaccines arrive, reported Bloomberg.

  • "We are focusing very heavily now on treatment of early infection and, or prevention of infection," Fauci told JAMA in an interview Friday, "and that's the bridge to the vaccine."

  • Antibody-based medications, other blood products from recovered patients and antivirals are being investigated as early treatments, Fauci noted.

  • Meanwhile, immunization against SARS-CoV-2 could begin in the US in November or December, Fauci said, but it will probably take until at least the third quarter of 2021 for enough Americans to have been protected against the pandemic virus to significantly diminish its threat.

  • Fauci said 100 million doses of vaccine may be produced by December, with all six companies supplying the US slated to have made 700 million doses by next April.